APOLIPOPROTEIN-E AND APOLIPOPROTEIN-B POLYMORPHISMS - LONGEVITY FACTORS ASSESSED IN NONAGENARIANS

被引:130
作者
KERVINEN, K
SAVOLAINEN, MJ
SALOKANNEL, J
HYNNINEN, A
HEIKKINEN, J
EHNHOLM, C
KOISTINEN, MJ
KESANIEMI, YA
机构
[1] UNIV OULU, DEPT INTERNAL MED, SF-90220 OULU, FINLAND
[2] UNIV OULU, BIOCTR OULU, SF-90220 OULU, FINLAND
[3] NATL PUBL HLTH INST, HELSINKI, FINLAND
基金
芬兰科学院;
关键词
APOLIPOPROTEINS; CHOLESTEROL; LIPOPROTEIN(A); LIPIDS; ARTERIOSCLEROSIS; AGING; GENETICS; LONGEVITY;
D O I
10.1016/0021-9150(94)90011-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To test if the prevalence of genetic risk factors for coronary heart disease (CHD) is low in individuals who have reached an extremely old age, the allele frequencies of apolipoprotein E (ape E) and B (ape B) polymorphisms and plasma lipoprotein(a) levels were investigated in nonagenarians and in younger control groups. The frequency of the epsilon 4 allele of apo E was significantly lower in the nonagenarians than in the middle-aged and young adults (P < 0.05). Also, the frequency of EcoRI allele R- of apo B was low in the nonagenarians, whereas the allele frequency for the XbaI polymorphism of apo B and plasma lipoprotein(a) concentrations did not differ between the nonagenarians and the younger groups. These findings strongly suggest that the presence of these potential genetic risk factors for CHD, namely the epsilon 4 allele of apo E and the R- allele of apo B, decreases the probability of an individual reaching an extremely old age.
引用
收藏
页码:89 / 95
页数:7
相关论文
共 29 条
  • [1] BERG K, 1974, CLIN GENET, V6, P230
  • [2] ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY
    DAHLEN, GH
    GUYTON, JR
    ATTAR, M
    FARMER, JA
    KAUTZ, JA
    GOTTO, AM
    [J]. CIRCULATION, 1986, 74 (04) : 758 - 765
  • [3] Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100
  • [4] APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS
    DAVIGNON, J
    GREGG, RE
    SING, CF
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 1 - 21
  • [5] EHNHOLM C, 1986, J LIPID RES, V27, P227
  • [6] APOLIPOPROTEIN GENETIC-VARIATION IN THE ASSESSMENT OF ATHEROSCLEROSIS SUSCEPTIBILITY
    HEGELE, RA
    BRESLOW, JL
    [J]. GENETIC EPIDEMIOLOGY, 1987, 4 (03) : 163 - 184
  • [7] APOLIPOPROTEIN B-GENE DNA POLYMORPHISMS ASSOCIATED WITH MYOCARDIAL-INFARCTION
    HEGELE, RA
    HUANG, LS
    HERBERT, PN
    BLUM, CB
    BURING, JE
    HENNEKENS, CH
    BRESLOW, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) : 1509 - 1515
  • [8] LIPOPROTEIN(A) AND CORONARY HEART-DISEASE RISK - A NESTED CASE-CONTROL STUDY OF THE HELSINKI HEART-STUDY PARTICIPANTS
    JAUHIAINEN, M
    KOSKINEN, P
    EHNHOLM, C
    FRICK, MH
    MANTTARI, M
    MANNINEN, V
    HUTTUNEN, JK
    [J]. ATHEROSCLEROSIS, 1991, 89 (01) : 59 - 67
  • [9] PREVALENCE OF ASYMPTOMATIC MYOCARDIAL-ISCHEMIA IN DIABETIC SUBJECTS
    KOISTINEN, MJ
    [J]. BRITISH MEDICAL JOURNAL, 1990, 301 (6743) : 92 - 95
  • [10] APOPROTEIN-E POLYMORPHISM AND CORONARY-ARTERY DISEASE - INCREASED PREVALENCE OF APOLIPOPROTEIN E-4 IN ANGIOGRAPHICALLY VERIFIED CORONARY PATIENTS
    KUUSI, T
    NIEMINEN, MS
    EHNHOLM, C
    YKIJARVINEN, H
    VALLE, M
    NIKKILA, EA
    TASKINEN, MR
    [J]. ARTERIOSCLEROSIS, 1989, 9 (02): : 237 - 241